Market short interest shifts in September reports
Short interest surged sharply at one firm while dropping at others amid broader Nasdaq and ETF position changes.

Coverage momentum
total articles across this storyline · last 72h1,543
articles now
2,905
peak · 3:00 PM
+126%
vs. first half
Key developments
Short interest fell sharply across five U.S. ETFs as of Sept. 30, with some dropping over 99%.
September short interest rose sharply for Hansa Biopharma, Revelation Biosciences, Sunshine Biopharma and QHSLab.
September short interest rose 131% for Pacer American Energy Independence ETF and 176.2% for Pacer Swan SOS Moderate ETF.
430 sources on this →September Short Interest Rises Across Five Securities including TDK, TryHard Holdings, and four funds.
351 sources on this →
Coverage across the spectrum
Claim check
What each side asserts, disputes — or leaves out entirely.












